Clinical trials
Completed Sleep Initiation and Maintenance Disorders trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idorsia Pharmaceuticals Ltd. | 8 |
| GlaxoSmithKline | 5 |
| Sanofi | 4 |
| ARCIM Institute Academic Research in Complementary and Integrative Medicine | 3 |
| Janssen Research & Development, LLC | 3 |
| Eisai Inc. | 2 |
| Midnight Pharma, LLC | 2 |
| Philipps University Marburg | 2 |
| Biologische Heilmittel Heel GmbH | 1 |
| Charite University, Berlin, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Initiation and Maintenance Disorders | 42 |
| Anxiety Disorders | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Breast Neoplasms | 1 |
| Chronic Disease | 1 |
| Chronic Pain | 1 |
| Fatigue | 1 |
| Fractures, Stress | 1 |
| Heart Valve Diseases | 1 |
| Major Depressive Disorder | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.